This article is intended for primary care clinicians, obstetricians, pulmonary medicine specialists, allergists, and other specialists who care for children at risk of developing atopic disease.
The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.
Upon completion of this activity, participants will be able to:
As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should only claim credit commensurate with the extent of their participation in the activity. Medscape Medical News has been reviewed and is acceptable for up to 350 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins 09/01/08. Term of approval is for 1 year from this date. This activity is approved for 0.25 Prescribed credits. Credit may be claimed for 1 year from the date of this activity.
Note: Total credit is subject to change based on topic selection and article length.
This Activity is sponsored by Medscape Continuing Education Provider Unit.
Medscape is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APNs; None of these credits is in the area of pharmacology.
Provider Number: 6FDKKC-PRV-05
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page.
Follow these steps to earn CME/CE credit*:
CME/CE Released: 1/8/2008
Valid for credit through: 2/10/2010
processing....
January 8, 2008 — The American Academy of Pediatrics (AAP) has issued an updated policy statement that reviews the nutritional options during pregnancy, lactation, and the first year of life that may or may not affect the development of atopic disease. The new recommendations, which discuss the role of maternal dietary restriction, breast-feeding, timing of introduction of complementary foods, and hydrolyzed formulas, are published in the January issue of Pediatrics.
"This clinical report reviews the nutritional options during pregnancy, lactation, and the first year of life that may affect the development of atopic disease (atopic dermatitis, asthma, food allergy) in early life," write Frank R. Greer, MD, and colleagues from the AAP Committee on Nutrition and Section on Allergy and Immunology. "It replaces an earlier policy statement from the American Academy of Pediatrics that addressed the use of hypoallergenic infant formulas and included provisional recommendations for dietary management for the prevention of atopic disease. The documented benefits of nutritional intervention that may prevent or delay the onset of atopic disease are largely limited to infants at high risk of developing allergy (ie, infants with at least 1 first-degree relative [parent or sibling] with allergic disease)."
The evidence reviewed does not support a major role for maternal dietary restrictions during pregnancy or lactation. However, breast-feeding for at least 4 months vs feeding formula made with intact cow's milk protein seems to prevent or delay development of atopic dermatitis, cow's milk allergy, and wheezing in early childhood.
Studies of infants who are at high risk for atopy and who are not exclusively breast-fed for 4 to 6 months offer modest evidence suggesting that use of hydrolyzed formulas may delay or prevent the onset of atopic disease vs formula made with intact cow's milk protein. This especially seems to be the case for atopic dermatitis. However, not all hydrolyzed formulas protect to the same extent, based on comparative studies.
"There is also little evidence that delaying the timing of the introduction of complementary foods beyond 4 to 6 months of age prevents the occurrence of atopic disease," the study authors write. "At present, there are insufficient data to document a protective effect of any dietary intervention beyond 4 to 6 months of age for the development of atopic disease." The study authors then summarize, "It is evident that inadequate study design and/or a paucity of data currently limit the ability to draw firm conclusions about certain aspects of atopy prevention through dietary interventions."
Bearing in mind these limitations, the study authors make the following recommendations:
"Additional studies are needed to document the long-term effect of dietary interventions in infancy to prevent atopic disease, especially in children older than 4 years and in adults," the study authors conclude. "This document describes means to prevent or delay atopic diseases through dietary changes. For a child who has developed an atopic disease that may be precipitated or exacerbated by ingested proteins (via human milk, infant formula, or specific complementary foods), treatment may require specific identification and restriction of causal food proteins."
Pediatrics. 2008;121:183-191.
Although the increased prevalence of asthma among children in the United States has been well documented, there is evidence that these illnesses are becoming more common in other parts of the world as well. A study of Austrian children by Schernhammer and colleagues, which was published in the December 14, 2007, issue of Pediatric Allergy and Immunology, compared rates of atopic disease among children between 1995 and 2003. Among children between the ages of 6 to 7 years, there was evidence of an interval increase in the prevalence of physician-diagnosed asthma (+16%), hay fever (+22%), and eczema (+37%). The respective increases in prevalence of these illnesses among children between the ages of 12 and 14 years were 32%, 19%, and 28%.
Nutrition has been implicated as 1 possible reason for the general rise in the prevalence of atopic disease among children. The current clinical report summarizes the scientific evidence and recommendations regarding this issue.